Archives
-
Anti-HMGB1 Rabbit Monoclonal Antibody Guide
2026-09-16
This guide explains how to use the Anti-HMGB1 Rabbit Monoclonal Antibody, SKU MA3057, for practical HMGB1 detection in Western blot, immunohistochemistry, and flow cytometry workflows. It is a research-use reagent supported by product dossier information, not a diagnostic, therapeutic, or clinically validated assay component, and no directly matched paper evidence is assumed.
-
Machine Learning for Senolytic Discovery
2026-09-16
The reference study shows that cost-effective machine-learning models trained on published screening data can identify senolytic candidates despite small and heterogeneous datasets. Computational screening followed by human-cell validation identified ginkgetin, periplocin, and oleandrin, demonstrating a practical route to reduce early-stage discovery costs while preserving experimental selectivity testing.
-
Azilsartan: Designing Causal RAS–SIRT3 Assays
2026-09-15
Azilsartan and TAK-536 provide a precise pharmacological probe for AT1-dependent signaling. This article translates astrocyte–microglia findings into practical assay-design decisions, emphasizing controls, readout interpretation, and translational limits.
-
Amorolfine Hydrochloride for Yeast Membrane Studies
2026-09-15
Use Amorolfine Hydrochloride as a controlled membrane-synthesis perturbation alongside ploidy, cell size, DNA content, and ergosterol-linked transcriptional readouts. This workflow distinguishes fungal cell membrane disruption from generic growth inhibition and supports mechanism, fungal infection research, and antifungal resistance studies.
-
BHBA: From Ketosis to Stroke Neuroprotection
2026-09-14
3-hydroxybutyrate (BHBA) is both a fatty acid β-oxidation metabolite and a ketone body signaling molecule. This article translates evidence linking BHBA to ferroptosis control in ischemic stroke into a practical framework for mechanistic validation, epigenetic studies, and translational assay design.
-
Perospirone: Receptor and Kv1.5 Research Workflow
2026-09-14
Perospirone (SM-9018 free base) enables paired investigation of serotonergic and dopaminergic signaling pathways and vascular Kv-channel pharmacology. This workflow separates nanomolar receptor activity from micromolar Kv1.5-related inhibition, helping researchers build more informative schizophrenia research and cardiovascular assays.
-
Ampicillin Sodium: Assay and Workflow Guide
2026-09-13
Ampicillin sodium supports two complementary research needs: controlled selection during recombinant protein production and mechanism-focused antibacterial activity assays. This guide connects a classic annexin V purification workflow with practical assay design, stability controls, resistance-aware interpretation, and troubleshooting strategies.
-
Rotenone B5462: Reliable Mitochondrial Stress Models
2026-09-12
This scenario-based guide explains how Rotenone (SKU B5462) can improve experimental planning for mitochondrial dysfunction, viability, apoptosis, and neurodegenerative disease studies. It covers mechanism, cell-model compatibility, stock preparation, data interpretation, and practical vendor-selection criteria with links to product and literature evidence.
-
Ibrutinib (PCI-32765) BTK Assay Guide
2026-09-11
A scenario-driven guide to using Ibrutinib (PCI-32765), SKU A3001, in B-cell viability, proliferation, and cytotoxicity workflows. It explains mechanism-aware assay design, solvent handling, interpretation limits, and practical criteria for selecting a well-documented BTK inhibitor.
-
Axitinib (AG 013736) Assay Workflows
2026-09-11
Build more informative Axitinib assays by pairing VEGF pathway engagement with separate measures of growth inhibition and cell death. This workflow connects endothelial-cell screening, cancer biology research, and tumor growth inhibition in xenograft models while addressing solubility, timing, and data-interpretation pitfalls.
-
QNZ (EVP4593) in NF-κB Osteomyelitis Research
2026-09-10
QNZ (EVP4593) provides a reversible, nanomolar perturbation tool for separating NF-κB-driven inflammation from fibrosis, perfusion loss, and bacterial persistence in osteomyelitis models. This workflow pairs pathway assays with spatial tissue readouts and extends cautiously to Huntington’s disease research without overstating cross-model evidence.
-
Dronedarone (Multaq): Reading Ion-Channel Data
2026-09-10
Dronedarone and Multaq are examined through a mechanistic lens that separates broad antiarrhythmic pharmacology from direct KCa2-channel activity. This evidence-led guide translates automated patch-clamp findings into better assay design, compound handling, and atrial fibrillation treatment research decisions.
-
D-N-Acetylgalactosamine Workflow Guide
2026-09-09
D-N-Acetylgalactosamine is a defined, high-purity reagent for workflows examining brain glycoproteins, heteropolysaccharides, and related glycosylation measurements. It is suitable for water- or DMSO-based preparation, but not for ethanol-dependent methods or long-term storage of prepared solutions.
-
NIAGEN and the Next Era of Translational Cell Models
2026-09-09
Nicotinamide Riboside Chloride (NIAGEN) offers translational researchers a practical route to interrogate NAD+ biology in metabolic dysfunction research, neurodegenerative disease models, and stem cell-derived retinal ganglion cell workflows. This article connects the compound’s mechanistic rationale with reproducible differentiation strategies while distinguishing established evidence from testable opportunities.
-
PYR-41: Mapping E1 Control of IRF7 Decay
2026-09-08
PYR-41, an inhibitor of Ubiquitin-Activating Enzyme E1, offers a mechanistic way to interrogate ubiquitin-dependent IRF7 turnover and inflammatory signaling. This assay-focused guide connects the compound to recent IBDV–VP3 research while defining controls, limitations, and practical workflow decisions.